Perilla frutescens BRITTON (perilla, Labiatae) is a medicinal herb prescribed in Saiboku-to ( ), which is a Kampo formula effective for allergic diseases such as bronchial asthma. The present study was conducted to evaluate the anti-allergic effect of orally administered perilla decoction and to identify the active constituents using mice ear-passive cutaneous anaphylaxis (PCA)-reaction, which is one of the animal models for type I allergy. Perilla decoction significantly suppressed PCA-reaction, and the inhibition % at the dose of 500 mg/kg was 43%. The perilla decoction contains 5.3% of luteolin 7
Industrial advances have brought about chemical pollution in our surroundings, and patients suffering from allergic diseases such as bronchial asthma and atopic dermatitis are heavily affected. Allergies are now the most prevalent and rapidly increasing chronic health problem in industrialized countries. The treatment of allergic diseases is based mainly on allergen avoidance and the use of anti-histamines, steroids, or immunosuppressants. Japanese traditional herbal medicine (Kampo medicine) has recently been advanced for the treatment of allergic diseases, and its effectiveness has received increasing attention. 1) One Kampo formula, Saibokuto ( ) is clinically used to treat bronchial asthma, and its effectiveness is well documented. [2] [3] [4] [5] Saiboku-to consists of ten herbs, and the Perilla Herb is believed to be one of the components active in the anti-allergic activity of this formula. 6) The Perilla Herb is dried leaves of Perilla frutescens BRIT-TON (perilla, Labiatae), and it is reported to have pharmacological activity as a sedative, 7) for indigestion, 8) or food poisoning. 9) Previous in vivo studies showed that intraperitoneal injection of perilla decoction suppressed antigen-specific IgE production in mice, 10) histamine-release from peritoneal mast cells in rats 11) and induced Th1-type cytokines in mice, 12) suggesting that perilla has anti-allergic activities. However, since herbal medicines are usually administered orally, the anti-allergic effects of perilla and its active constituents
have not yet been completely demonstrated. In our previous study, we identified 4 phenolic compounds:
, scutellarin, and rosmarinic acid, from perilla decoction as the active constituents suppressing the proliferation of cultured murine mesangial cells, and demonstrated that only rosmarinic acid represents the anti-proliferative effect of perilla decoction.
13) The present study was conducted to evaluate the anti-allergic effect of orally administered perilla decoction and to identify the contribution of the 4 previously isolated phenolic compounds to the effect of original perilla decoction using passive cutaneous anaphylaxis (PCA)-reaction induced in the ears of mice, which is one of the animal models for type I allergy. 14) We also measured the content of an active constituent in Saiboku-to to discuss the contribution of perilla or its constituents to the anti-allergic activity of Saiboku-to.
MATERIALS AND METHODS

Materials
Herbal medicines used in this study all conformed to Japanese Pharmacopoeia XIII and were purchased from Tochimoto Tenkaido (Osaka, Japan). Ovalbumin (OVA) was purchased from Seikagaku Corporation (Tokyo, Japan). Tranilast was generously supplied by Kissei Pharmaceutical Co., Ltd. (Tokyo). Rosmarinic acid was bought from Extrasynthése (Genay, France).
Preparation of the Decoctions Perilla decoction was prepared by boiling 200 g of Perilla Herb in 4 l of distilled water for 1 h (dried weight, 40 g). A standard decoction of Saiboku-to was prepared by boiling 10 herbal medicine mixtures (3.0 g of Magnolia Bark, 2.0 g of Perilla Herb, 7.0 g of Bupleum Root, 5.0 g of Pinellia Tuber, 1.0 g of Ginger, 3.0 g of Scutellaria Root, 3.0 g of Ginseng, 3.0 g of Jujube, 2.0 g of Glycyrrhiza and 5.0 g of Poria Sclerotium) in 680 ml distilled water for 1 h (dried weight, 7.0 g; extract ratio: 21%).
Isolation of Phenolic Constituents Leaves of P. frutescens forma viridis were harvested in the experimental garden of Amino-Up Chemical Co., Ltd. (Sapporo, Japan) in August, 2000, and 300 g of the dried leaves were boiled in 6 l 
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min).
Each compound was applied to the column, and the calibration lines were made from their peak areas. Quantifiable ranges of these compounds were 0.2-2 mg of 1, 0.1-1 mg of 2, 0.04-0.4 mg of 3, 0.1-1 mg of rosmarinic acid. Data were expressed with mean percentages (weight of the compounds/dried weight of perilla decoction %) in two different quantitative analyses.
Quantitation of Rosmarinic Acid in Saiboku-to Standard decoction of Saiboku-to (dried weight, 500 mg) and marketing extract-granules of Saiboku-to (Matsuura Industries, Nagoya, Japan) (500 mg) were applied to HPLC (YMC J'sphere ODS-H80, 150ϫ4.6 mm I.D.; mobile phase, H 2 O/ MeOH/AcOH 60 : 30 : 0.1→45 : 55 : 0.1, 0→30 min linear gradient; flow rate, 1 ml/min; temperature, 40°C; detection, UV absorption at 328 nm) to give a peak of rosmarinic acid (t R 22.8 min). Rosmarinic acid was applied to the column, and the calibration line (25-250 ng) was made from its peak area. Data was expressed with mean percentages (weight of rosmarinic acid/dried weight of Saiboku-to decoction %) from two different quantitative analyses.
Preparation for Anti-OVA Serum The procedure employed was a slight modification of the method of Inagaki et al. 15) Ovalbumin was suspended in 20 mg/ml Al(OH) 3 solution (final concentration of OVA, 10 mg/ml), and 0.2 ml of this suspension (OVA, 2 mg) was intraperitoneally injected into 4-week-old female Balb/c mice (Japan SLC, Hamamatsu, Japan) 5 times at 2 week intervals. Ten days after the 5th injection of OVA, whole blood was collected to obtain anti-OVA serum.
PCA-Reaction Ten microliters of 30-fold diluted anti-OVA serum was intracutaneously injected into both ears of 6-week-old male ddY mice (Japan SLC). In the background group, saline was intracutaneously injected instead of antiserum. After 48 h, OVA (10 mg/kg body weight) in saline containing 0.5% evansblue (Merck, Dermstadt, Germany) was intravenously injected to induce the PCA-reaction. Perilla decoction and its constituents were orally administered to mice 30 min before antigen-challenge. As a positive control, tranilast was used at a dose of 500 mg/kg. Thirty minutes after antigen-challenge, mice were sacrificed and their ears were collected. The ears were dissolved in 300 ml of 1 N KOH and evansblue was extracted with 700 ml of acetone/10 N phosphoric acid 67 : 3. The concentration of evansblue was measured colorimetrically at 620 nm. Data were expressed as amount of evansblue per ears and as inhibition %, which was calculated using the following equation:
Statistical Analysis Data were expressed as meanϮS.E. One-way analysis of variance (ANOVA) followed by a multiple comparison procedure according to Fisher's protected least significant difference (PLSD) was employed to evaluate the effect of perilla decoction. Student's t-test was employed for comparison between the control and compound-treated groups. A difference of pϽ0.05 was considered significant.
RESULTS AND DISCUSSION
Perilla Herb (200 g) was extracted in boiling water according to the standard formation process of Kampo decoctions to yield perilla decoction (dried weight, 40 g; extract ratio, 20%), and then the suppressive effect of the decoction on mice ear-PCA-reaction was evaluated. Compared with the background group, cutaneous injection of anti-OVA serum induced prominent enhancement of vascular permeability as exhibited by dye elusion into the ears in the control mice; this was significantly, but not dose-dependently, suppressed by oral treatment of perilla decoction, and the maximum suppressive effect was observed at the dose of 500 mg/kg (inhibition %, 43%, pϽ0.01, Fig. 1 ). Kampo medicine sometimes exhibits anti-dose-dependent pharmacological effects, since it contains several constituents and its entire pharmacological effect is explained as the sum of each constituent. In the fol- lowing experiment, the doses of perilla extract and its constituents were determined to be equivalent to 500 mg/kg of perilla extract, and the isolation of the active constituents in perilla decoction was attempted.
In our previous study, we identified 4 phenolic com- (3), and rosmarinic acid, from perilla decoction as the active constituents suppressing the proliferation of cultured murine mesangial cells (Fig. 2) .
13) The quantitative analysis of these phenolic compounds in the perilla decoction revealed that their contents were 5.3% of 1, 1.6% of 2, 0.49% of 3, and 2.5% of rosmarinic acid, respectively. Then, the contribution of these compounds to the anti-allergic effect of perilla decoction was evaluated. Figure 3 shows the effect of oral treatment of perilla decoction (500 mg/kg) and the relative amount of each constituent (27 mg/kg of 1, 8.0 mg/kg of 2, 2.7 mg/kg of 3, and 13 mg/kg of rosmarinic acid) on PCA reaction induced in the ears of mice. Compound 2 and rosmarinic acid significantly suppressed PCA-reaction, and the inhibition % was 32% (pϽ0.05) and 41% (pϽ0.01), respectively. Since the inhibition % of perilla decoction and rosmarinic acid were nearly equal, it is proposed that rosmarinic acid was the representative anti-allergic constituent in the decoction, and compound 2 partly contributed to the decoction's effect. The combination of these compounds may explain the anti-dose-dependent effect of perilla decoction. Inhibition % of rosmarinic acid at the dose of 13 mg/kg (41%) was comparable to that of tranilast at the dose of 500 mg/kg (50%), indicating that the anti-allergic titer of rosmarinic acid was much higher than tranilast. As the anti-allergic constituent of perilla decoction, glycoprotein (ca. 6.0 kDa), which suppressed histamine-release from cultured mast cells, was isolated from perilla aqueous extract. 16) However, when perilla decoction was administered orally, such macromolecular compounds would not contribute to the anti-allergic effect of perilla decoction, since they were hardly absorbed from the gastrointestinal tract into the circulation.
Saiboku-to is a well-known Kampo formula used for allergic bronchial asthma, 2, 3) and Perilla Herb is believed to be one of the active herbs in the formula. 6) We therefore sought to evaluate whether rosmarinic acid could be identified as the anti-allergic constituent of Saiboku-to. Figure 4 depicts a HPLC-profile of the Saiboku-to standard decoction prepared in our laboratory. Quantitative analysis revealed that the Saiboku-to made in our laboratory and the marketing extractgranule of Saiboku-to contained 0.013% and 0.0049% of rosmarinic acid, respectively. These values indicated that the daily dose of rosmarinic acid in adult would be 0.89 and 0.22 mg/50 kg, respectively, and those amounts are too low to exhibit anti-allergic activity. Since Saiboku-to is clinically useful for allergic diseases 2, 3) and suppresses some allergic reactions in experimental models, 4, 5) other anti-allergic compounds than rosmarinic acid must be contained in Saibokuto. Previous study revealed that magnolol, liquiritigenin and wogonin were identified in the urine collected from patients treated with Saiboku-to, suggesting that these compounds would be actual active constituents of Saiboku-to. 18, 19) Our present study suggests that rosmarinic acid and Perilla Herb could not be active constituents of Saiboku-to in their anti-allergic activities. Since by Kampo theory, the target patients of Saiboku-to usually have restlessness, fear, and a tendency toward depression, 20) Perilla Herb may be prescribed as part of Saiboku-to in order to exhibit its sedative activity. 8) In conclusion, oral treatment of perilla decoction suppresses allergic reaction in mice, and the active constituents are rosmarinic acid and apigenin-diglucuronide. The anti-allergic titer of rosmarinic acid is higher than tranilast, and rosmarinic acid is a promising compound to prevent or treat al- lergic diseases.
